89bio, Inc. ETNB
Set alert
14.84 0.00 0.00%
At close · Oct 30
14.84 Day range 14.84
52-week range unavailable
- YTD
- +89.77%
- 1 year
- +85.73%
- Open
- 14.84
- Prev close
- 14.84
- Mkt cap
- 2.20B
- Vol
- 38.51M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.84
- High
- 14.84
- Forward P/E
- -5.17
- Beta
- 1.26
- Short ratio
- 0.74
- Inst. own
- 103.69%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 12.52
- 200-d avg
- 9.87
- 1y target
- 30.38
Financial health
Altman Z-Score
12.50 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -2.2×
FY 2018 5y median -4.3× FY 2024
P/S 0.0×
FY 2018 5y median 0.0× FY 2024
P/B 2.0×
FY 2018 5y median 2.0× FY 2024
P/FCF -2.2×
FY 2018 5y median -5.5× FY 2024
EV/EBITDA -2.0×
FY 2018 5y median -3.8× FY 2024
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2024
FCF Yield -44.9%
FY 2018 5y median -18.3% FY 2024
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2024
ROE -91.6%
FY 2018 5y median -67.2% FY 2024
ROIC -86.8%
FY 2018 5y median -26.7% FY 2024
ROA -76.7%
FY 2018 5y median -51.8% FY 2024
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2024
Operating Income -154.4%
FY 2018 FY 2024
EPS (diluted) -75.5%
FY 2018 FY 2024
Free Cash Flow -184.7%
FY 2018 FY 2024
Financial Health
Current Ratio 13.2×
FY 2018 5y median 13.2× FY 2024
Quick Ratio 13.2×
FY 2018 5y median 13.2× FY 2024
Debt / Equity 0.1×
FY 2018 5y median 0.1× FY 2024
Net Debt / EBITDA 0.2×
FY 2018 5y median 0.4× FY 2024
Interest Coverage -102×
FY 2018 5y median -42.2× FY 2024
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31